Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 June 2007, Vol. 109, No. 12, pp. 5522-5523.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scott, K.
Right arrow Articles by Allan, J. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Scott, K.
Right arrow Articles by Allan, J. M.
Related Collections
Right arrowRelated Articles in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

CORRESPONDENCE

RAG1 and BRCA2 polymorphisms in non-Hodgkin lymphoma

To the editor:

A recent Blood paper by Hill et al1 suggested a link between the risk of developing non-Hodgkin lymphoma (NHL) and polymorphic variations in several genes involved in DNA strand break induction and DNA repair pathways. We examined 2 of these polymorphisms where Hill et al reported statistically significant associations, in the Recombination-activating 1 (RAG1) gene (K820R; odds ratio [OR] = 2.7 [AA vs GG], 95% confidence interval [CI], 1.4-5.0) and the Breast cancer 2 (BRCA2) gene (N372H; OR = 1.5 [AA vs CC], 95% CI, 1.0-2.1), in a United Kingdom case-control study of lymphoma.

Local ethical approval was obtained for this research. Informed consent was obtained in accordance with the Declaration of Helsinki.

A total of 741 white patients with NHL and 806 white control participants randomly selected from population registers were recruited as part of a lymphoma case-control study conducted in parts of north and southwest England.2 Our study participants consented to give a blood sample, and represented 67% of patients with incident NHL aged 16 to 69 years in the study area and 66% of the control participants who were contacted successfully. We genotyped the participants' DNA while blinded to case-control status using TaqMan SNP genotyping assays (Applied Biosystems, Warrington, United Kingdom) and ABI PRISM 7000 software (Applied Biosystems). To assess the reliability of the Taqman assays, 20 samples were randomly selected for direct DNA sequencing: concordance with TaqMan was 100% for both polymorphisms. Among our control population, RAG1 K820R and BRCA2 N372H were in Hardy-Weinberg equilibrium, and the distributions of variants were consistent with those reported by Hill et al and the cancer genome anatomy project SNP500 cancer database.3 Unmatched statistical analyses to estimate ORs and 95% CIs were conducted using unconditional logistic regression adjusting for age and sex,4 and the likelihood ratio test was used to test for interactions.

We observed a modest but nonsignificant decrease in risk of NHL with BRCA2 N372H AC and CC variants compared with the AA variant, and no evidence of any association between NHL and the RAG1 K820R polymorphism (Table 1). Risks for B-cell lymphoma, and the 2 major diagnostic subgroups of diffuse large B-cell lymphoma and follicular lymphoma (data not shown), were similar to those for total NHL for both variants, while risk estimates were elevated for T-cell lymphoma, but were not significant (Table 1). Risks were generally similar among men and women, and varied little by age (data not shown). However, for T-cell lymphoma, men who carried at least 1 copy of the BRCA2 N372H C allele had a significantly increased risk (OR = 2.30, 95% CI, 1.08-4.87 based on 23 patients and 194 control participants with the C allele compared with 11 patients and 208 control participants), while women were at decreased risk (OR = 0.43, 95% CI, 0.17-1.06 based on 7 patients and 176 control participants with the C allele compared with 17 patients and 179 control participants) (test for interaction: {chi}2 = 8.42, P = .004).


View this table:
[in this window]
[in a new window]

 
Table 1. Number of patients and control participants, adjusted ORs, and 95% CIs for BRCA2 N372H and RAG1 K820R by immunophenotype

 
Our data suggest that there is little association between NHL and either of these 2 polymorphisms. However, we cannot exclude the possibility of an association, and further investigation is required using larger datasets to elucidate the role of these polymorphisms in determining the risk of developing NHL.

Authorship

Correspondence: Kathryn Scott, Department of Biology, University of York, York. United Kingdom YO10 5YW; e-mail: KS27{at}YORK.AC.UK

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Kathryn Scott, Peter J. Adamson, Sharon L. Barrans, Lisa J. Worrillow, Eleanor V. Willett, and James M. Allan

References

  1. Hill DA, Wang SS, Cerhan JR, et al. Risk of Non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Blood 2006; 108:3161–3167.[Abstract/Free Full Text]

  2. Willett EV, Smith AG, Dovey GJ, et al. Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma. Cancer Causes Control 2004; 15:771–780.[CrossRef][Medline] [Order article via Infotrieve]

  3. National Cancer Institute. Cancer Genome Anatomy Project SNP500 Cancer Database. Available at: http://snp500cancer.nci.nih.gov. Accessed June 2006.

  4. Breslow NE and Day NE. Classical methods of analysis of matched data. Statistical methods in cancer research: the analysis of case-control studies volume 1. 1980;Lyon International Agency for Research in Cancer162–189.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles in Blood Online:

NHL and genomic variability in RAG1 and BRCA2
Deirdre A. Hill, Sophia Wang, Patricia Hartge, and Nathaniel Rothman
Blood 2007 109: 5523. [Full Text] [PDF]

Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes
Deirdre A. Hill, Sophia S. Wang, James R. Cerhan, Scott Davis, Wendy Cozen, Richard K. Severson, Patricia Hartge, Sholom Wacholder, Meredith Yeager, Stephen J. Chanock, and Nathaniel Rothman
Blood 2006 108: 3161-3167. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scott, K.
Right arrow Articles by Allan, J. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Scott, K.
Right arrow Articles by Allan, J. M.
Related Collections
Right arrowRelated Articles in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020